FOV#,PanCK,Gene Name,Expression Relative to PanCK,"Breast Cancer, RNA Expression, Patient Information",Age,Sex,Organ/Anatomic Site,Pathology diagnosis,TNM,Grade,Stage,Type,Tissue ID.,ER,PR,HER2
481,Low,PEAK1,Medium,,53,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.82,-,3,,Metastasis,Fmg020963,-,-,-
481,Low,VCL,High,,,,,,,,,Metastasis,,-,-,-
481,Low,INHBA,High,,,,,,,,,Metastasis,,-,-,-
481,Low,CD36,Medium,,,,,,,,,Metastasis,,-,-,-
481,Low,HSPA5,High,,,,,,,,,Metastasis,,-,-,-
481,Low,TDGF1,Medium,,,,,,,,,Metastasis,,-,-,-
481,Low,Nodal,Medium,,,,,,,,,Metastasis,,-,-,-
481,Low,VIM,Medium,,,,,,,,,Metastasis,,-,-,-
486,Low,PEAK1,Low,,53,F,Breast,Invasive carcinoma of no special type,T4N2M0,3,IIIB,Malignant,Fmg020963,-,-,-
486,Low,VCL,Medium,,,,,,,,,Malignant,,-,-,-
486,Low,INHBA,Low,,,,,,,,,Malignant,,-,-,-
486,Low,CD36,Low,,,,,,,,,Malignant,,-,-,-
486,Low,HSPA5,High,,,,,,,,,Malignant,,-,-,-
486,Low,TDGF1,Low,,,,,,,,,Malignant,,-,-,-
486,Low,Nodal,Low,,,,,,,,,Malignant,,-,-,-
486,Low,VIM,Low,,,,,,,,,Malignant,,-,-,-
492,Low,PEAK1,Low,,80,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.58,-,3,,Metastasis,Fmg010939,-,-,+
492,Low,VCL,Low,,,,,,,,,Metastasis,,-,-,+
492,Low,INHBA,Low,,,,,,,,,Metastasis,,-,-,+
492,Low,CD36,Low,,,,,,,,,Metastasis,,-,-,+
492,Low,HSPA5,Low,,,,,,,,,Metastasis,,-,-,+
492,Low,TDGF1,Low,,,,,,,,,Metastasis,,-,-,+
492,Low,Nodal,Low,,,,,,,,,Metastasis,,-,-,+
492,Low,VIM,Low,,,,,,,,,Metastasis,,-,-,+
500,Low,PEAK1,Low,,80,F,Breast,Invasive carcinoma of no special type,T2N2M0,2,IIIA,Malignant,Fmg010939,+,-,+
500,Low,VCL,Medium,,,,,,,,,Malignant,,+,-,+
500,Low,INHBA,High,,,,,,,,,Malignant,,+,-,+
500,Low,CD36,Medium,,,,,,,,,Malignant,,+,-,+
500,Low,HSPA5,High,,,,,,,,,Malignant,,+,-,+
500,Low,TDGF1,Medium,,,,,,,,,Malignant,,+,-,+
500,Low,Nodal,Low,,,,,,,,,Malignant,,+,-,+
500,Low,VIM,Medium,,,,,,,,,Malignant,,+,-,+
505,Medium,PEAK1,Low,,45,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.34,-,3,,Metastasis,Fmg040344,+,+,+
505,Medium,VCL,Medium,,,,,,,,,Metastasis,,+,+,+
505,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,+,+
505,Medium,CD36,Low,,,,,,,,,Metastasis,,+,+,+
505,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,+,+,+
505,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,+,+,+
505,Medium,Nodal,Medium,,,,,,,,,Metastasis,,+,+,+
505,Medium,VIM,Low,,,,,,,,,Metastasis,,+,+,+
509,Medium,PEAK1,Low,,45,F,Breast,Invasive carcinoma of no special type,T3N1M0,2,IIIA,Malignant,Fmg040344,+,+,+
509,Medium,VCL,Medium,,,,,,,,,Malignant,,+,+,+
509,Medium,INHBA,Low,,,,,,,,,Malignant,,+,+,+
509,Medium,CD36,Low,,,,,,,,,Malignant,,+,+,+
509,Medium,HSPA5,Medium,,,,,,,,,Malignant,,+,+,+
509,Medium,TDGF1,Medium,,,,,,,,,Malignant,,+,+,+
509,Medium,Nodal,Low,,,,,,,,,Malignant,,+,+,+
509,Medium,VIM,Low,,,,,,,,,Malignant,,+,+,+
515,Medium,PEAK1,0,,52,F,Breast,Cancer adjacent breast tissue of No.10,,-,,AT,Fmg020652,+,+,-
515,Medium,VCL,Low,,,,,,,,,AT,,+,+,-
515,Medium,INHBA,Low,,,,,,,,,AT,,+,+,-
515,Medium,CD36,0,,,,,,,,,AT,,+,+,-
515,Medium,HSPA5,Low,,,,,,,,,AT,,+,+,-
515,Medium,TDGF1,Low,,,,,,,,,AT,,+,+,-
515,Medium,Nodal,0,,,,,,,,,AT,,+,+,-
515,Medium,VIM,Medium,,,,,,,,,AT,,+,+,-
429,Low,PEAK1,Low,,38,F,Breast,Cancer adjacent breast tissue of No.9 ,,-,,AT,Fmg020320,+,+,-
429,Low,VCL,Low,,,,,,,,,AT,,+,+,-
429,Low,INHBA,Low,,,,,,,,,AT,,+,+,-
429,Low,CD36,Low,,,,,,,,,AT,,+,+,-
429,Low,HSPA5,Low,,,,,,,,,AT,,+,+,-
429,Low,TDGF1,Low,,,,,,,,,AT,,+,+,-
429,Low,Nodal,Low,,,,,,,,,AT,,+,+,-
429,Low,VIM,Medium,,,,,,,,,AT,,+,+,-
136,Low,PEAK1,Medium,,49,F,Breast,Invasive carcinoma of no special type,T3N1M0,1--2,IIIA,Malignant,Fmg050520,+,-,+
136,Low,VCL,High,,,,,,,,,Malignant,,+,-,+
136,Low,INHBA,High,,,,,,,,,Malignant,,+,-,+
136,Low,CD36,Medium,,,,,,,,,Malignant,,+,-,+
136,Low,HSPA5,High,,,,,,,,,Malignant,,+,-,+
136,Low,TDGF1,High,,,,,,,,,Malignant,,+,-,+
136,Low,Nodal,Medium,,,,,,,,,Malignant,,+,-,+
136,Low,VIM,High,,,,,,,,,Malignant,,+,-,+
129,Low,PEAK1,0,,49,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.33,-,3,,Metastasis,Fmg050520,-,-,-
129,Low,VCL,Low,,,,,,,,,Metastasis,,-,-,-
129,Low,INHBA,Low,,,,,,,,,Metastasis,,-,-,-
129,Low,CD36,0,,,,,,,,,Metastasis,,-,-,-
129,Low,HSPA5,Low,,,,,,,,,Metastasis,,-,-,-
129,Low,TDGF1,0,,,,,,,,,Metastasis,,-,-,-
129,Low,Nodal,Low,,,,,,,,,Metastasis,,-,-,-
129,Low,VIM,Low,,,,,,,,,Metastasis,,-,-,-
37,High,PEAK1,Medium,,28,F,Breast,Invasive carcinoma of no special type,T2N2M0,2,IIIA,Malignant,Fmg020572,+,+,+
37,High,VCL,High,,,,,,,,,Malignant,,+,+,+
37,High,INHBA,Medium,,,,,,,,,Malignant,,+,+,+
37,High,CD36,Low,,,,,,,,,Malignant,,+,+,+
37,High,HSPA5,High,,,,,,,,,Malignant,,+,+,+
37,High,TDGF1,Medium,,,,,,,,,Malignant,,+,+,+
37,High,Nodal,Low,,,,,,,,,Malignant,,+,+,+
37,High,VIM,Medium,,,,,,,,,Malignant,,+,+,+
31,High,PEAK1,Low,,28,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.57,-,3,,Metastasis,Fmg020572,+,+,+
31,High,VCL,Medium,,,,,,,,,Metastasis,,+,+,+
31,High,INHBA,Medium,,,,,,,,,Metastasis,,+,+,+
31,High,CD36,Medium,,,,,,,,,Metastasis,,+,+,+
31,High,HSPA5,High,,,,,,,,,Metastasis,,+,+,+
31,High,TDGF1,Medium,,,,,,,,,Metastasis,,+,+,+
31,High,Nodal,Low,,,,,,,,,Metastasis,,+,+,+
31,High,VIM,Low,,,,,,,,,Metastasis,,+,+,+
5,Medium,PEAK1,Low,,78,F,Breast,Invasive carcinoma of no special type,T4N1M0,2,IIIB,Malignant,Fmg021308,-,-,+
5,Medium,VCL,Medium,,,,,,,,,Malignant,,-,-,+
5,Medium,INHBA,Medium,,,,,,,,,Malignant,,-,-,+
5,Medium,CD36,Low,,,,,,,,,Malignant,,-,-,+
5,Medium,HSPA5,Low,,,,,,,,,Malignant,,-,-,+
5,Medium,TDGF1,Low,,,,,,,,,Malignant,,-,-,+
5,Medium,Nodal,Low,,,,,,,,,Malignant,,-,-,+
5,Medium,VIM,Medium,,,,,,,,,Malignant,,-,-,+
436,Medium,PEAK1,Low,,78,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.81,-,3,,Metastasis,Fmg021308,-,-,-
436,Medium,VCL,Medium,,,,,,,,,Metastasis,,-,-,-
436,Medium,INHBA,High,,,,,,,,,Metastasis,,-,-,-
436,Medium,CD36,Low,,,,,,,,,Metastasis,,-,-,-
436,Medium,HSPA5,Low,,,,,,,,,Metastasis,,-,-,-
436,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,-,-,-
436,Medium,Nodal,Medium,,,,,,,,,Metastasis,,-,-,-
436,Medium,VIM,Low,,,,,,,,,Metastasis,,-,-,-
439,High,PEAK1,Medium,,48,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.80 (sparse),-,3,,Metastasis,Fmg021467,+,-,+
439,High,VCL,High,,,,,,,,,Metastasis,,+,-,+
439,High,INHBA,Medium,,,,,,,,,Metastasis,,+,-,+
439,High,CD36,Medium,,,,,,,,,Metastasis,,+,-,+
439,High,HSPA5,High,,,,,,,,,Metastasis,,+,-,+
439,High,TDGF1,High,,,,,,,,,Metastasis,,+,-,+
439,High,Nodal,High,,,,,,,,,Metastasis,,+,-,+
439,High,VIM,Medium,,,,,,,,,Metastasis,,+,-,+
10,Medium,PEAK1,Low,,48,F,Breast,Invasive carcinoma of no special type,T2N1M0,3,IIB,Malignant,Fmg021467,-,-,+
10,Medium,VCL,Medium,,,,,,,,,Malignant,,-,-,+
10,Medium,INHBA,Low,,,,,,,,,Malignant,,-,-,+
10,Medium,CD36,Medium,,,,,,,,,Malignant,,-,-,+
10,Medium,HSPA5,Low,,,,,,,,,Malignant,,-,-,+
10,Medium,TDGF1,Medium,,,,,,,,,Malignant,,-,-,+
10,Medium,Nodal,Low,,,,,,,,,Malignant,,-,-,+
10,Medium,VIM,Low,,,,,,,,,Malignant,,-,-,+
23,High,PEAK1,Low,,48,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.56,-,3,,Metastasis,Fmg020768,+,+,-
23,High,VCL,Medium,,,,,,,,,Metastasis,,+,+,-
23,High,INHBA,Medium,,,,,,,,,Metastasis,,+,+,-
23,High,CD36,Low,,,,,,,,,Metastasis,,+,+,-
23,High,HSPA5,Medium,,,,,,,,,Metastasis,,+,+,-
23,High,TDGF1,Medium,,,,,,,,,Metastasis,,+,+,-
23,High,Nodal,Medium,,,,,,,,,Metastasis,,+,+,-
23,High,VIM,Low,,,,,,,,,Metastasis,,+,+,-
176,High,PEAK1,Low,,48,F,Breast,Invasive carcinoma of no special type,T2N1M0,2,IIB,Malignant,Fmg020768,+,+,-
176,High,VCL,Medium,,,,,,,,,Malignant,,+,+,-
176,High,INHBA,Medium,,,,,,,,,Malignant,,+,+,-
176,High,CD36,Medium,,,,,,,,,Malignant,,+,+,-
176,High,HSPA5,High,,,,,,,,,Malignant,,+,+,-
176,High,TDGF1,High,,,,,,,,,Malignant,,+,+,-
176,High,Nodal,Low,,,,,,,,,Malignant,,+,+,-
176,High,VIM,Low,,,,,,,,,Malignant,,+,+,-
122,Medium,PEAK1,Medium,,58,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.32,-,3,,Metastasis,Fmg060617,+,-,+
122,Medium,VCL,High,,,,,,,,,Metastasis,,+,-,+
122,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,-,+
122,Medium,CD36,Medium,,,,,,,,,Metastasis,,+,-,+
122,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,+,-,+
122,Medium,TDGF1,Low,,,,,,,,,Metastasis,,+,-,+
122,Medium,Nodal,Low,,,,,,,,,Metastasis,,+,-,+
122,Medium,VIM,Low,,,,,,,,,Metastasis,,+,-,+
149,Medium,PEAK1,Medium,,58,F,Breast,Invasive carcinoma of no special type,T2N3M0,1--2,IIIC,Malignant,Fmg060617,+,-,+
149,Medium,VCL,High,,,,,,,,,Malignant,,+,-,+
149,Medium,INHBA,High,,,,,,,,,Malignant,,+,-,+
149,Medium,CD36,Medium,,,,,,,,,Malignant,,+,-,+
149,Medium,HSPA5,High,,,,,,,,,Malignant,,+,-,+
149,Medium,TDGF1,Medium,,,,,,,,,Malignant,,+,-,+
149,Medium,Nodal,Low,,,,,,,,,Malignant,,+,-,+
149,Medium,VIM,Low,,,,,,,,,Malignant,,+,-,+
422,Low,PEAK1,Low,,37,F,Breast,Cancer adjacent breast tissue of No.8 (fibrous tissue),,-,,AT,Fmg020323,+,+,-
422,Low,VCL,Medium,,,,,,,,,AT,,+,+,-
422,Low,INHBA,Low,,,,,,,,,AT,,+,+,-
422,Low,CD36,Low,,,,,,,,,AT,,+,+,-
422,Low,HSPA5,Low,,,,,,,,,AT,,+,+,-
422,Low,TDGF1,Low,,,,,,,,,AT,,+,+,-
422,Low,Nodal,Low,,,,,,,,,AT,,+,+,-
422,Low,VIM,Low,,,,,,,,,AT,,+,+,-
406,Medium,PEAK1,Low,,51,F,Breast,NAT breast tissue of No.7,,-,,AT,Fmg020326,+,+,-
406,Medium,VCL,Medium,,,,,,,,,AT,,+,+,-
406,Medium,INHBA,Low,,,,,,,,,AT,,+,+,-
406,Medium,CD36,Low,,,,,,,,,AT,,+,+,-
406,Medium,HSPA5,Low,,,,,,,,,AT,,+,+,-
406,Medium,TDGF1,Low,,,,,,,,,AT,,+,+,-
406,Medium,Nodal,Low,,,,,,,,,AT,,+,+,-
406,Medium,VIM,Medium,,,,,,,,,AT,,+,+,-
158,Medium,PEAK1,Medium,,54,F,Breast,Invasive carcinoma of no special type,T2N1M0,1--2,IIB,Malignant,Fmg060809,-,-,-
158,Medium,VCL,High,,,,,,,,,Malignant,,-,-,-
158,Medium,INHBA,High,,,,,,,,,Malignant,,-,-,-
158,Medium,CD36,Medium,,,,,,,,,Malignant,,-,-,-
158,Medium,HSPA5,Medium,,,,,,,,,Malignant,,-,-,-
158,Medium,TDGF1,Medium,,,,,,,,,Malignant,,-,-,-
158,Medium,Nodal,Medium,,,,,,,,,Malignant,,-,-,-
158,Medium,VIM,High,,,,,,,,,Malignant,,-,-,-
112,Medium,PEAK1,Medium,,54,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.31,-,3,,Metastasis,Fmg060809,-,-,-
112,Medium,VCL,Medium,,,,,,,,,Metastasis,,-,-,-
112,Medium,INHBA,Medium,,,,,,,,,Metastasis,,-,-,-
112,Medium,CD36,Low,,,,,,,,,Metastasis,,-,-,-
112,Medium,HSPA5,High,,,,,,,,,Metastasis,,-,-,-
112,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,-,-,-
112,Medium,Nodal,Medium,,,,,,,,,Metastasis,,-,-,-
112,Medium,VIM,Medium,,,,,,,,,Metastasis,,-,-,-
69,High,PEAK1,Low,,46,F,Breast,Invasive carcinoma of no special type,T3N2M0,3,IIIA,Malignant,Fmg020771,-,-,+
69,High,VCL,Medium,,,,,,,,,Malignant,,-,-,+
69,High,INHBA,Medium,,,,,,,,,Malignant,,-,-,+
69,High,CD36,Low,,,,,,,,,Malignant,,-,-,+
69,High,HSPA5,Medium,,,,,,,,,Malignant,,-,-,+
69,High,TDGF1,Medium,,,,,,,,,Malignant,,-,-,+
69,High,Nodal,Medium,,,,,,,,,Malignant,,-,-,+
69,High,VIM,Low,,,,,,,,,Malignant,,-,-,+
59,Medium,PEAK1,Medium,,46,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.55,-,3,,Metastasis,Fmg020771,+,-,+
59,Medium,VCL,High,,,,,,,,,Metastasis,,+,-,+
59,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,-,+
59,Medium,CD36,High,,,,,,,,,Metastasis,,+,-,+
59,Medium,HSPA5,Low,,,,,,,,,Metastasis,,+,-,+
59,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,+,-,+
59,Medium,Nodal,Medium,,,,,,,,,Metastasis,,+,-,+
59,Medium,VIM,Low,,,,,,,,,Metastasis,,+,-,+
50,Medium,PEAK1,Medium,,33,F,Breast,Invasive carcinoma of no special type,T3N3M0,3,IIIC,Malignant,Fmg021542,-,-,-
50,Medium,VCL,High,,,,,,,,,Malignant,,-,-,-
50,Medium,INHBA,Medium,,,,,,,,,Malignant,,-,-,-
50,Medium,CD36,Medium,,,,,,,,,Malignant,,-,-,-
50,Medium,HSPA5,High,,,,,,,,,Malignant,,-,-,-
50,Medium,TDGF1,Medium,,,,,,,,,Malignant,,-,-,-
50,Medium,Nodal,Medium,,,,,,,,,Malignant,,-,-,-
50,Medium,VIM,High,,,,,,,,,Malignant,,-,-,-
445,Medium,PEAK1,Low,,33,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.79,-,3,,Metastasis,Fmg021542,-,-,-
445,Medium,VCL,High,,,,,,,,,Metastasis,,-,-,-
445,Medium,INHBA,Medium,,,,,,,,,Metastasis,,-,-,-
445,Medium,CD36,Medium,,,,,,,,,Metastasis,,-,-,-
445,Medium,HSPA5,High,,,,,,,,,Metastasis,,-,-,-
445,Medium,TDGF1,Low,,,,,,,,,Metastasis,,-,-,-
445,Medium,Nodal,Low,,,,,,,,,Metastasis,,-,-,-
445,Medium,VIM,Medium,,,,,,,,,Metastasis,,-,-,-
451,High,PEAK1,Low,,73,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.78,-,3,,Metastasis,Fmg021690,+,+,+
451,High,VCL,High,,,,,,,,,Metastasis,,+,+,+
451,High,INHBA,Low,,,,,,,,,Metastasis,,+,+,+
451,High,CD36,Low,,,,,,,,,Metastasis,,+,+,+
451,High,HSPA5,High,,,,,,,,,Metastasis,,+,+,+
451,High,TDGF1,0,,,,,,,,,Metastasis,,+,+,+
451,High,Nodal,Medium,,,,,,,,,Metastasis,,+,+,+
451,High,VIM,Medium,,,,,,,,,Metastasis,,+,+,+
77,Medium,PEAK1,Low,,73,F,Breast,Invasive carcinoma of no special type,T4N1M0,3,IIIB,Malignant,Fmg021690,+,+,+
77,Medium,VCL,High,,,,,,,,,Malignant,,+,+,+
77,Medium,INHBA,0,,,,,,,,,Malignant,,+,+,+
77,Medium,CD36,Low,,,,,,,,,Malignant,,+,+,+
77,Medium,HSPA5,High,,,,,,,,,Malignant,,+,+,+
77,Medium,TDGF1,Medium,,,,,,,,,Malignant,,+,+,+
77,Medium,Nodal,Medium,,,,,,,,,Malignant,,+,+,+
77,Medium,VIM,0,,,,,,,,,Malignant,,+,+,+
85,High,PEAK1,Low,,58,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.54,-,3,,Metastasis,Fmg021040,+,-,-
85,High,VCL,Medium,,,,,,,,,Metastasis,,+,-,-
85,High,INHBA,Medium,,,,,,,,,Metastasis,,+,-,-
85,High,CD36,Low,,,,,,,,,Metastasis,,+,-,-
85,High,HSPA5,Medium,,,,,,,,,Metastasis,,+,-,-
85,High,TDGF1,Low,,,,,,,,,Metastasis,,+,-,-
85,High,Nodal,Medium,,,,,,,,,Metastasis,,+,-,-
85,High,VIM,Medium,,,,,,,,,Metastasis,,+,-,-
95,Medium,PEAK1,Medium,,58,F,Breast,Invasive carcinoma of no special type,T2N2M0,2,IIIA,Malignant,Fmg021040,+,+,-
95,Medium,VCL,Medium,,,,,,,,,Malignant,,+,+,-
95,Medium,INHBA,High,,,,,,,,,Malignant,,+,+,-
95,Medium,CD36,Medium,,,,,,,,,Malignant,,+,+,-
95,Medium,HSPA5,Low,,,,,,,,,Malignant,,+,+,-
95,Medium,TDGF1,Low,,,,,,,,,Malignant,,+,+,-
95,Medium,Nodal,Medium,,,,,,,,,Malignant,,+,+,-
95,Medium,VIM,Medium,,,,,,,,,Malignant,,+,+,-
104,Medium,PEAK1,Medium,,30,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.30,-,3,,Metastasis,Fmg090018,+,+,+
104,Medium,VCL,High,,,,,,,,,Metastasis,,+,+,+
104,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,+,+
104,Medium,CD36,Low,,,,,,,,,Metastasis,,+,+,+
104,Medium,HSPA5,High,,,,,,,,,Metastasis,,+,+,+
104,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,+,+,+
104,Medium,Nodal,Medium,,,,,,,,,Metastasis,,+,+,+
104,Medium,VIM,High,,,,,,,,,Metastasis,,+,+,+
167,Low,PEAK1,Medium,,30,F,Breast,Invasive carcinoma of no special type,T2N1M0,2,IIB,Malignant,Fmg090018,+,-,+
167,Low,VCL,High,,,,,,,,,Malignant,,+,-,+
167,Low,INHBA,Low,,,,,,,,,Malignant,,+,-,+
167,Low,CD36,Medium,,,,,,,,,Malignant,,+,-,+
167,Low,HSPA5,Medium,,,,,,,,,Malignant,,+,-,+
167,Low,TDGF1,Medium,,,,,,,,,Malignant,,+,-,+
167,Low,Nodal,Low,,,,,,,,,Malignant,,+,-,+
167,Low,VIM,Medium,,,,,,,,,Malignant,,+,-,+
401,0,PEAK1,0,,59,F,Breast,NAT breast tissue of No.6 (fibrous tissue),,-,,NAT,Fmg010537,-,-,-
401,0,VCL,0,,,,,,,,,NAT,,-,-,-
401,0,INHBA,0,,,,,,,,,NAT,,-,-,-
401,0,CD36,0,,,,,,,,,NAT,,-,-,-
401,0,HSPA5,0,,,,,,,,,NAT,,-,-,-
401,0,TDGF1,0,,,,,,,,,NAT,,-,-,-
401,0,Nodal,0,,,,,,,,,NAT,,-,-,-
401,0,VIM,0,,,,,,,,,NAT,,-,-,-
392,Medium,PEAK1,Low,,50,F,Breast,NAT breast tissue of No.5,,-,,NAT,Fmg021275,+,+,-
392,Medium,VCL,Medium,,,,,,,,,NAT,,+,+,-
392,Medium,INHBA,Medium,,,,,,,,,NAT,,+,+,-
392,Medium,CD36,0,,,,,,,,,NAT,,+,+,-
392,Medium,HSPA5,Medium,,,,,,,,,NAT,,+,+,-
392,Medium,TDGF1,Low,,,,,,,,,NAT,,+,+,-
392,Medium,Nodal,Low,,,,,,,,,NAT,,+,+,-
392,Medium,VIM,Medium,,,,,,,,,NAT,,+,+,-
217,Medium,PEAK1,Medium,,46,F,Breast,Invasive carcinoma of no special type,T1N1M0,1,IIA,Malignant,Fmg060810,+,+,-
217,Medium,VCL,Medium,,,,,,,,,Malignant,,+,+,-
217,Medium,INHBA,Low,,,,,,,,,Malignant,,+,+,-
217,Medium,CD36,Medium,,,,,,,,,Malignant,,+,+,-
217,Medium,HSPA5,High,,,,,,,,,Malignant,,+,+,-
217,Medium,TDGF1,Medium,,,,,,,,,Malignant,,+,+,-
217,Medium,Nodal,Medium,,,,,,,,,Malignant,,+,+,-
217,Medium,VIM,Medium,,,,,,,,,Malignant,,+,+,-
212,Low,PEAK1,Medium,,46,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.29,-,3,,Metastasis,Fmg060810,+,+,-
212,Low,VCL,High,,,,,,,,,Metastasis,,+,+,-
212,Low,INHBA,Low,,,,,,,,,Metastasis,,+,+,-
212,Low,CD36,Low,,,,,,,,,Metastasis,,+,+,-
212,Low,HSPA5,High,,,,,,,,,Metastasis,,+,+,-
212,Low,TDGF1,Medium,,,,,,,,,Metastasis,,+,+,-
212,Low,Nodal,Low,,,,,,,,,Metastasis,,+,+,-
212,Low,VIM,Medium,,,,,,,,,Metastasis,,+,+,-
203,Medium,PEAK1,Low,,45,F,Breast,Invasive carcinoma of no special type,T2N1M0,2,IIB,Malignant,Fmg021276,+,+,+
203,Medium,VCL,Medium,,,,,,,,,Malignant,,+,+,+
203,Medium,INHBA,Low,,,,,,,,,Malignant,,+,+,+
203,Medium,CD36,Low,,,,,,,,,Malignant,,+,+,+
203,Medium,HSPA5,Medium,,,,,,,,,Malignant,,+,+,+
203,Medium,TDGF1,Medium,,,,,,,,,Malignant,,+,+,+
203,Medium,Nodal,Medium,,,,,,,,,Malignant,,+,+,+
203,Medium,VIM,Low,,,,,,,,,Malignant,,+,+,+
194,Medium,PEAK1,Low,,45,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.53,-,3,,Metastasis,Fmg021276,+,+,+
194,Medium,VCL,Medium,,,,,,,,,Metastasis,,+,+,+
194,Medium,INHBA,Low,,,,,,,,,Metastasis,,+,+,+
194,Medium,CD36,Low,,,,,,,,,Metastasis,,+,+,+
194,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,+,+,+
194,Medium,TDGF1,Low,,,,,,,,,Metastasis,,+,+,+
194,Medium,Nodal,Low,,,,,,,,,Metastasis,,+,+,+
194,Medium,VIM,0,,,,,,,,,Metastasis,,+,+,+
181,Medium,PEAK1,Low,,58,F,Breast,Invasive carcinoma of no special type,T4N1M0,3,IIIB,Malignant,Fmg030897,-,-,-
181,Medium,VCL,Medium,,,,,,,,,Malignant,,-,-,-
181,Medium,INHBA,Medium,,,,,,,,,Malignant,,-,-,-
181,Medium,CD36,Low,,,,,,,,,Malignant,,-,-,-
181,Medium,HSPA5,Medium,,,,,,,,,Malignant,,-,-,-
181,Medium,TDGF1,Low,,,,,,,,,Malignant,,-,-,-
181,Medium,Nodal,Low,,,,,,,,,Malignant,,-,-,-
181,Medium,VIM,High,,,,,,,,,Malignant,,-,-,-
460,Medium,PEAK1,Low,,58,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.77,-,3,,Metastasis,Fmg030897,-,-,-
460,Medium,VCL,High,,,,,,,,,Metastasis,,-,-,-
460,Medium,INHBA,Medium,,,,,,,,,Metastasis,,-,-,-
460,Medium,CD36,Low,,,,,,,,,Metastasis,,-,-,-
460,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,-,-,-
460,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,-,-,-
460,Medium,Nodal,Low,,,,,,,,,Metastasis,,-,-,-
460,Medium,VIM,High,,,,,,,,,Metastasis,,-,-,-
466,High,PEAK1,Low,,50,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.76,-,3,,Metastasis,Fmg040683,+,-,-
466,High,VCL,High,,,,,,,,,Metastasis,,+,-,-
466,High,INHBA,Medium,,,,,,,,,Metastasis,,+,-,-
466,High,CD36,Low,,,,,,,,,Metastasis,,+,-,-
466,High,HSPA5,High,,,,,,,,,Metastasis,,+,-,-
466,High,TDGF1,Medium,,,,,,,,,Metastasis,,+,-,-
466,High,Nodal,Low,,,,,,,,,Metastasis,,+,-,-
466,High,VIM,Medium,,,,,,,,,Metastasis,,+,-,-
266,Medium,PEAK1,Low,,50,F,Breast,Invasive carcinoma of no special type,T4N2M0,2,IIIB,Malignant,Fmg040683,+,+,-
266,Medium,VCL,Medium,,,,,,,,,Malignant,,+,+,-
266,Medium,INHBA,Low,,,,,,,,,Malignant,,+,+,-
266,Medium,CD36,Low,,,,,,,,,Malignant,,+,+,-
266,Medium,HSPA5,Medium,,,,,,,,,Malignant,,+,+,-
266,Medium,TDGF1,Low,,,,,,,,,Malignant,,+,+,-
266,Medium,Nodal,Low,,,,,,,,,Malignant,,+,+,-
266,Medium,VIM,Low,,,,,,,,,Malignant,,+,+,-
257,High,PEAK1,Low,,52,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.52,-,2,,Metastasis,Fmg021279,+,-,-
257,High,VCL,Medium,,,,,,,,,Metastasis,,+,-,-
257,High,INHBA,Low,,,,,,,,,Metastasis,,+,-,-
257,High,CD36,Low,,,,,,,,,Metastasis,,+,-,-
257,High,HSPA5,Medium,,,,,,,,,Metastasis,,+,-,-
257,High,TDGF1,Low,,,,,,,,,Metastasis,,+,-,-
257,High,Nodal,Low,,,,,,,,,Metastasis,,+,-,-
257,High,VIM,Low,,,,,,,,,Metastasis,,+,-,-
248,High,PEAK1,Low,,52,F,Breast,Invasive carcinoma of no special type,T2N1M0,2,IIB,Malignant,Fmg021279,+,-,-
248,High,VCL,High,,,,,,,,,Malignant,,+,-,-
248,High,INHBA,Low,,,,,,,,,Malignant,,+,-,-
248,High,CD36,Medium,,,,,,,,,Malignant,,+,-,-
248,High,HSPA5,High,,,,,,,,,Malignant,,+,-,-
248,High,TDGF1,Medium,,,,,,,,,Malignant,,+,-,-
248,High,Nodal,Medium,,,,,,,,,Malignant,,+,-,-
248,High,VIM,Low,,,,,,,,,Malignant,,+,-,-
236,High,PEAK1,Low,,39,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.28,-,3,,Metastasis,Fmg021019,+,-,-
236,High,VCL,Medium,,,,,,,,,Metastasis,,+,-,-
236,High,INHBA,Medium,,,,,,,,,Metastasis,,+,-,-
236,High,CD36,Low,,,,,,,,,Metastasis,,+,-,-
236,High,HSPA5,Medium,,,,,,,,,Metastasis,,+,-,-
236,High,TDGF1,Low,,,,,,,,,Metastasis,,+,-,-
236,High,Nodal,Low,,,,,,,,,Metastasis,,+,-,-
236,High,VIM,Medium,,,,,,,,,Metastasis,,+,-,-
234,High,PEAK1,Low,,39,F,Breast,Invasive carcinoma of no special type,T3N1M0,1--2,IIIA,Malignant,Fmg021019,+,-,-
234,High,VCL,Medium,,,,,,,,,Malignant,,+,-,-
234,High,INHBA,High,,,,,,,,,Malignant,,+,-,-
234,High,CD36,Medium,,,,,,,,,Malignant,,+,-,-
234,High,HSPA5,Medium,,,,,,,,,Malignant,,+,-,-
234,High,TDGF1,Medium,,,,,,,,,Malignant,,+,-,-
234,High,Nodal,Medium,,,,,,,,,Malignant,,+,-,-
234,High,VIM,Low,,,,,,,,,Malignant,,+,-,-
380,Medium,PEAK1,Low,,42,F,Breast,NAT breast tissue of No.4,,-,,NAT,Fmg031176,+,+,-
380,Medium,VCL,Medium,,,,,,,,,NAT,,+,+,-
380,Medium,INHBA,Low,,,,,,,,,NAT,,+,+,-
380,Medium,CD36,Low,,,,,,,,,NAT,,+,+,-
380,Medium,HSPA5,Low,,,,,,,,,NAT,,+,+,-
380,Medium,TDGF1,Medium,,,,,,,,,NAT,,+,+,-
380,Medium,Nodal,Low,,,,,,,,,NAT,,+,+,-
380,Medium,VIM,Medium,,,,,,,,,NAT,,+,+,-
374,Medium,PEAK1,Low,,44,F,Breast,Cancer adjacent breast tissue of No.3,,-,,AT,Fmg020543,+,+,-
374,Medium,VCL,Medium,,,,,,,,,AT,,+,+,-
374,Medium,INHBA,Low,,,,,,,,,AT,,+,+,-
374,Medium,CD36,Low,,,,,,,,,AT,,+,+,-
374,Medium,HSPA5,Low,,,,,,,,,AT,,+,+,-
374,Medium,TDGF1,Medium,,,,,,,,,AT,,+,+,-
374,Medium,Nodal,Low,,,,,,,,,AT,,+,+,-
374,Medium,VIM,Medium,,,,,,,,,AT,,+,+,-
309,High,PEAK1,Low,,57,F,Breast,Invasive carcinoma of no special type,T2N2M0,2,IIIA,Malignant,Fmg030562,+,+,+
309,High,VCL,Medium,,,,,,,,,Malignant,,+,+,+
309,High,INHBA,Medium,,,,,,,,,Malignant,,+,+,+
309,High,CD36,Low,,,,,,,,,Malignant,,+,+,+
309,High,HSPA5,Medium,,,,,,,,,Malignant,,+,+,+
309,High,TDGF1,0,,,,,,,,,Malignant,,+,+,+
309,High,Nodal,Low,,,,,,,,,Malignant,,+,+,+
309,High,VIM,Medium,,,,,,,,,Malignant,,+,+,+
302,Medium,PEAK1,Low,,57,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.27,-,2,,Metastasis,Fmg030562,+,-,+
302,Medium,VCL,Medium,,,,,,,,,Metastasis,,+,-,+
302,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,-,+
302,Medium,CD36,Low,,,,,,,,,Metastasis,,+,-,+
302,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,+,-,+
302,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,+,-,+
302,Medium,Nodal,Low,,,,,,,,,Metastasis,,+,-,+
302,Medium,VIM,Low,,,,,,,,,Metastasis,,+,-,+
294,Medium,PEAK1,Low,,45,F,Breast,Invasive carcinoma of no special type,T2N1M0,2,IIB,Malignant,Fmg021399,-,-,-
294,Medium,VCL,Low,,,,,,,,,Malignant,,-,-,-
294,Medium,INHBA,Low,,,,,,,,,Malignant,,-,-,-
294,Medium,CD36,Low,,,,,,,,,Malignant,,-,-,-
294,Medium,HSPA5,Low,,,,,,,,,Malignant,,-,-,-
294,Medium,TDGF1,Low,,,,,,,,,Malignant,,-,-,-
294,Medium,Nodal,Low,,,,,,,,,Malignant,,-,-,-
294,Medium,VIM,Medium,,,,,,,,,Malignant,,-,-,-
281,Medium,PEAK1,Low,,45,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.51,-,3,,Metastasis,Fmg021399,+,+,-
281,Medium,VCL,Medium,,,,,,,,,Metastasis,,+,+,-
281,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,+,-
281,Medium,CD36,Low,,,,,,,,,Metastasis,,+,+,-
281,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,+,+,-
281,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,+,+,-
281,Medium,Nodal,Low,,,,,,,,,Metastasis,,+,+,-
281,Medium,VIM,Medium,,,,,,,,,Metastasis,,+,+,-
274,High,PEAK1,Low,,44,F,Breast,Invasive carcinoma of no special type,T2N1M0,2,IIB,Malignant,Fmg050440,-,-,+
274,High,VCL,Low,,,,,,,,,Malignant,,-,-,+
274,High,INHBA,Low,,,,,,,,,Malignant,,-,-,+
274,High,CD36,Low,,,,,,,,,Malignant,,-,-,+
274,High,HSPA5,Low,,,,,,,,,Malignant,,-,-,+
274,High,TDGF1,Low,,,,,,,,,Malignant,,-,-,+
274,High,Nodal,Low,,,,,,,,,Malignant,,-,-,+
274,High,VIM,Low,,,,,,,,,Malignant,,-,-,+
472,High,PEAK1,Low,,44,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.75,-,3,,Metastasis,Fmg050440,-,-,+
472,High,VCL,Medium,,,,,,,,,Metastasis,,-,-,+
472,High,INHBA,Low,,,,,,,,,Metastasis,,-,-,+
472,High,CD36,Medium,,,,,,,,,Metastasis,,-,-,+
472,High,HSPA5,Low,,,,,,,,,Metastasis,,-,-,+
472,High,TDGF1,Medium,,,,,,,,,Metastasis,,-,-,+
472,High,Nodal,Medium,,,,,,,,,Metastasis,,-,-,+
472,High,VIM,Low,,,,,,,,,Metastasis,,-,-,+
476,High,PEAK1,Medium,,44,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.74,-,3,,Metastasis,Fm060814,+,-,+
476,High,VCL,High,,,,,,,,,Metastasis,,+,-,+
476,High,INHBA,Low,,,,,,,,,Metastasis,,+,-,+
476,High,CD36,Medium,,,,,,,,,Metastasis,,+,-,+
476,High,HSPA5,Medium,,,,,,,,,Metastasis,,+,-,+
476,High,TDGF1,Medium,,,,,,,,,Metastasis,,+,-,+
476,High,Nodal,Medium,,,,,,,,,Metastasis,,+,-,+
476,High,VIM,Low,,,,,,,,,Metastasis,,+,-,+
323,Medium,PEAK1,Low,,44,F,Breast,Invasive carcinoma of no special type,T2N1M0,3,IIB,Malignant,Fmg060814,-,-,-
323,Medium,VCL,Medium,,,,,,,,,Malignant,,-,-,-
323,Medium,INHBA,Medium,,,,,,,,,Malignant,,-,-,-
323,Medium,CD36,Low,,,,,,,,,Malignant,,-,-,-
323,Medium,HSPA5,Low,,,,,,,,,Malignant,,-,-,-
323,Medium,TDGF1,Medium,,,,,,,,,Malignant,,-,-,-
323,Medium,Nodal,Low,,,,,,,,,Malignant,,-,-,-
323,Medium,VIM,Low,,,,,,,,,Malignant,,-,-,-
329,Medium,PEAK1,Low,,71,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.50,-,2,,Metastasis,Fmg021405,+,-,-
329,Medium,VCL,Medium,,,,,,,,,Metastasis,,+,-,-
329,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,-,-
329,Medium,CD36,Medium,,,,,,,,,Metastasis,,+,-,-
329,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,+,-,-
329,Medium,TDGF1,Low,,,,,,,,,Metastasis,,+,-,-
329,Medium,Nodal,Low,,,,,,,,,Metastasis,,+,-,-
329,Medium,VIM,Medium,,,,,,,,,Metastasis,,+,-,-
341,Medium,PEAK1,Low,,71,F,Breast,Invasive carcinoma of no special type,T4N1M0,2,IIIB,Malignant,Fmg021405,-,-,-
341,Medium,VCL,Medium,,,,,,,,,Malignant,,-,-,-
341,Medium,INHBA,Low,,,,,,,,,Malignant,,-,-,-
341,Medium,CD36,Low,,,,,,,,,Malignant,,-,-,-
341,Medium,HSPA5,Low,,,,,,,,,Malignant,,-,-,-
341,Medium,TDGF1,Low,,,,,,,,,Malignant,,-,-,-
341,Medium,Nodal,Low,,,,,,,,,Malignant,,-,-,-
341,Medium,VIM,Low,,,,,,,,,Malignant,,-,-,-
344,Medium,PEAK1,Medium,,56,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.26,-,2,,Metastasis,Fmg020026,+,+,-
344,Medium,VCL,High,,,,,,,,,Metastasis,,+,+,-
344,Medium,INHBA,Medium,,,,,,,,,Metastasis,,+,+,-
344,Medium,CD36,High,,,,,,,,,Metastasis,,+,+,-
344,Medium,HSPA5,High,,,,,,,,,Metastasis,,+,+,-
344,Medium,TDGF1,Low,,,,,,,,,Metastasis,,+,+,-
344,Medium,Nodal,Medium,,,,,,,,,Metastasis,,+,+,-
344,Medium,VIM,High,,,,,,,,,Metastasis,,+,+,-
353,Medium,PEAK1,Low,,56,F,Breast,Invasive carcinoma of no special type,T2N1M0,1,IIB,Malignant,Fmg020026,-,-,-
353,Medium,VCL,Medium,,,,,,,,,Malignant,,-,-,-
353,Medium,INHBA,Low,,,,,,,,,Malignant,,-,-,-
353,Medium,CD36,Low,,,,,,,,,Malignant,,-,-,-
353,Medium,HSPA5,Low,,,,,,,,,Malignant,,-,-,-
353,Medium,TDGF1,Medium,,,,,,,,,Malignant,,-,-,-
353,Medium,Nodal,Low,,,,,,,,,Malignant,,-,-,-
353,Medium,VIM,Low,,,,,,,,,Malignant,,-,-,-
366,Low,PEAK1,0,,58,F,Breast,Ductal carcinoma in situ and cancer adjacent breast tissue of No.2,,-,,AT,Fmg021249,+,+,-
366,Low,VCL,0,,,,,,,,,AT,,+,+,-
366,Low,INHBA,0,,,,,,,,,AT,,+,+,-
366,Low,CD36,0,,,,,,,,,AT,,+,+,-
366,Low,HSPA5,0,,,,,,,,,AT,,+,+,-
366,Low,TDGF1,0,,,,,,,,,AT,,+,+,-
366,Low,Nodal,0,,,,,,,,,AT,,+,+,-
366,Low,VIM,0,,,,,,,,,AT,,+,+,-
533,0,PEAK1,0,,44,F,Breast,Cancer adjacent breast tissue of No.1,,-,,AT,Fmg021676,+,+,-
533,0,VCL,0,,,,,,,,,AT,,+,+,-
533,0,INHBA,0,,,,,,,,,AT,,+,+,-
533,0,CD36,0,,,,,,,,,AT,,+,+,-
533,0,HSPA5,0,,,,,,,,,AT,,+,+,-
533,0,TDGF1,0,,,,,,,,,AT,,+,+,-
533,0,Nodal,0,,,,,,,,,AT,,+,+,-
533,0,VIM,0,,,,,,,,,AT,,+,+,-
531,Low,PEAK1,Very High***,,48,F,Breast,Invasive carcinoma of no special type,T2N1M0,1,IIB,Malignant,Fmg180286,-,-,+
531,Low,VCL,Low,,,,,,,,,Malignant,,-,-,+
531,Low,INHBA,Low,,,,,,,,,Malignant,,-,-,+
531,Low,CD36,Low,,,,,,,,,Malignant,,-,-,+
531,Low,HSPA5,Medium,,,,,,,,,Malignant,,-,-,+
531,Low,TDGF1,Low,,,,,,,,,Malignant,,-,-,+
531,Low,Nodal,Low,,,,,,,,,Malignant,,-,-,+
531,Low,VIM,Low,,,,,,,,,Malignant,,-,-,+
530,Medium,PEAK1,Low,,48,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.25,-,2,,Metastasis,Fmg180286,-,-,+
530,Medium,VCL,Medium,,,,,,,,,Metastasis,,-,-,+
530,Medium,INHBA,Low,,,,,,,,,Metastasis,,-,-,+
530,Medium,CD36,Low,,,,,,,,,Metastasis,,-,-,+
530,Medium,HSPA5,Medium,,,,,,,,,Metastasis,,-,-,+
530,Medium,TDGF1,Medium,,,,,,,,,Metastasis,,-,-,+
530,Medium,Nodal,Low,,,,,,,,,Metastasis,,-,-,+
530,Medium,VIM,Medium,,,,,,,,,Metastasis,,-,-,+
528,VERY Low***,PEAK1,Low,,41,F,Breast,Invasive carcinoma of no special type,T2N2M0,2,IIIA,Malignant,Fmg030342,-,-,-
528,VERY Low***,VCL,Medium,,,,,,,,,Malignant,,-,-,-
528,VERY Low***,INHBA,Medium,,,,,,,,,Malignant,,-,-,-
528,VERY Low***,CD36,Low,,,,,,,,,Malignant,,-,-,-
528,VERY Low***,HSPA5,High,,,,,,,,,Malignant,,-,-,-
528,VERY Low***,TDGF1,Medium,,,,,,,,,Malignant,,-,-,-
528,VERY Low***,Nodal,Medium,,,,,,,,,Malignant,,-,-,-
528,VERY Low***,VIM,Low,,,,,,,,,Malignant,,-,-,-
526,0,PEAK1,0,,41,F,Lymph node,Metastatic invasive carcinoma of no special type from breast of No.49,-,3,,Metastasis,Fmg030342,-,-,-
526,0,VCL,0,,,,,,,,,Metastasis,,-,-,-
526,0,INHBA,0,,,,,,,,,Metastasis,,-,-,-
526,0,CD36,0,,,,,,,,,Metastasis,,-,-,-
526,0,HSPA5,0,,,,,,,,,Metastasis,,-,-,-
526,0,TDGF1,0,,,,,,,,,Metastasis,,-,-,-
526,0,Nodal,0,,,,,,,,,Metastasis,,-,-,-
526,0,VIM,0,,,,,,,,,Metastasis,,-,-,-
